Latest News

In its recently reported third quarter of fiscal 2026, Constellation Brands posted lower year-on-year sales and earnings, yet still exceeded analyst expectations and reaffirmed its full-year outlook while continuing dividends and share repurchases. Despite pressures on beer volumes and softer spending by key Hispanic consumers, the company preserved strong beer margins and highlighted steady demand for core brands like Corona and Modelo Especial, underlining the resilience of its portfolio...

Queen's Road Capital Investment (TSX:QRC) has opened 2026 with Q1 total revenue of US$69.9 million and basic EPS of US$1.36, backed by trailing twelve month revenue of US$128.3 million and EPS of US$2.50. The company has seen quarterly revenue range from US$61.8 million to US$86.1 million over the last year, with basic EPS moving between a loss of US$1.42 and a high of US$1.77 as trailing twelve month earnings climbed from US$0.40 to US$2.50 per share. With trailing net profit margins...

Earlier this month, SES AI Corporation presented at CES 2026 in Las Vegas and the Gordon Research Conference on Electrochemistry in Ventura, highlighting its latest advances in AI-enhanced battery technology. By sharing its electrochemistry research and AI-driven materials work on such high-profile stages, SES AI is potentially reinforcing its positioning with both technology partners and prospective enterprise users of its Molecular Universe platform. Next, we’ll explore how SES AI’s...

Recent attention on Manulife Financial (TSX:MFC) has picked up after an analyst upgraded the stock to a buy rating. Investors are also focusing on the insurer’s value metrics, capital returns, and asset management progress. See our latest analysis for Manulife Financial. The recent upgrade comes against a backdrop of firm price action, with Manulife’s 90 day share price return of 13.52% and 1 year total shareholder return of 26.11% pointing to momentum that has built steadily over time. If...

Recent commentary from major banks, including a downgrade of Nucor (NUE) by Morgan Stanley, alongside increased confidence in its prospects, has pushed the stock into focus for investors weighing steel sector exposure. See our latest analysis for Nucor. At a share price of US$165.97, Nucor has recently seen a 1 day share price return of 1.34% and a 90 day share price return of 19.83%, while its 1 year total shareholder return of 37.27% and 5 year total shareholder return of 223.44% point to...

With its stock down 32% over the past three months, it is easy to disregard Manas Polymers and Energies (NSE:MPEL). But...

What is driving interest in Fraser and Neave now? Fraser and Neave (SGX:F99) has come into focus after recent commentary highlighted possible margin improvement from lower raw material costs, as well as potential value creation from corporate actions within its wider beverage group. See our latest analysis for Fraser and Neave. Recent board and committee changes, together with the proposed final dividend of S$0.04 per share, have kept Fraser and Neave on investors’ radar. The relatively...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

MGIC Investment (MTG) has been drawing attention after recent share price swings, with the stock down about 4% over the past month but modestly positive over the past 3 months. See our latest analysis for MGIC Investment. Zooming out, MGIC Investment’s recent 1 month share price return of around a 4% decline and a softer 7 day move sit against a 1 year total shareholder return of 22.94%. This suggests momentum has cooled even as long term holders have seen solid gains. If MGIC’s recent...

A major US automaker’s decision to use Mobileye Global (MBLY) EyeQ6H chips for hands-free driving across millions of vehicles puts the company’s Surround ADAS technology at the center of evolving software-defined car platforms. See our latest analysis for Mobileye Global. Despite the new automaker deal and the planned Mentee Robotics acquisition, Mobileye’s share price return has been mixed, with a 30 day share price return of 3.34% but a 1 year total shareholder return decline of 26.99%,...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

If you are wondering whether AbbVie’s current share price reflects its underlying value, you are not alone. This article will walk through what the market might be pricing in. AbbVie recently closed at US$220.04, with a 0.1% decline over 7 days, a 1.5% decline over 30 days, a 4.0% decline year to date, but a 28.9% return over 1 year, 58.4% over 3 years and 139.2% over 5 years, which may prompt questions about how much optimism or risk is already in the price. Recent headlines around AbbVie...

Dividend announcement and why it matters now Fairfax Financial Holdings (TSX:FFH) has declared a dividend of US$15.00 per share, payable on January 22, 2026, to shareholders of record on January 15, 2026, with withholding tax for non residents. See our latest analysis for Fairfax Financial Holdings. Fairfax Financial Holdings’ latest dividend decision comes as the shares trade at CA$2,609.95, with a 30 day share price return of 6.54% and a 1 year total shareholder return of 36.32%. This...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Earlier this month, Maximus announced that its Board of Directors approved a quarterly cash dividend of US$0.33 per share, a 10% increase from the prior US$0.30, payable on March 2, 2026 to shareholders of record on February 13, 2026. This higher dividend underscores management’s willingness to return more cash to shareholders, which may reinforce perceptions of balance sheet strength and earnings resilience. We’ll now explore how this 10% dividend increase interacts with Maximus’ existing...

Conference updates and pipeline focus Vertex Pharmaceuticals (VRTX) has drawn fresh attention after outlining business and program updates ahead of its webcast at the 44th annual J.P. Morgan Healthcare Conference on January 12, 2026. See our latest analysis for Vertex Pharmaceuticals. Vertex’s recent program updates come after a steady run in the market, with a 90 day share price return of 11.73% and a 5 year total shareholder return of 104.21%, suggesting momentum has been building around...

It is hard to get excited after looking at Glottis' (NSE:GLOTTIS) recent performance, when its stock has declined 27...

Cameco, a major uranium producer with a sizeable stake in Westinghouse Electric, previously entered into an approximately US$80.00 billion U.S. government-backed agreement to build nuclear reactors across the country, highlighting its role across the nuclear fuel and reactor value chain. Recent sector-wide policy support, AI-driven power demand, and Cameco’s long-term utility contracts at unusually high price levels together underscore how its integrated exposure to uranium supply and...

PTC (PTC) is back on investors’ radar after recent share price softness, with the stock down over the past month and past 3 months. This has prompted fresh questions about how its software fundamentals line up with the current valuation. See our latest analysis for PTC. That recent 15.16% 90 day share price decline, alongside a 2.60% 30 day share price pullback, sits against a 0.78% year to date share price return and a mixed picture on longer term total shareholder returns, with gains over...

Rappid Valves (India) (NSE:RAPPID) has had a rough three months with its share price down 18%. However, stock prices...

CRH (CRH) is back in focus after a series of bullish analyst updates, an active share buyback program of up to US$300 million, and a clear tilt toward North American infrastructure and construction demand. See our latest analysis for CRH. Those buybacks and analyst updates come at a time when CRH’s 90 day share price return of 9.37% and 1 year total shareholder return of 45.08% suggest momentum has been building on top of a multi year compounding story. If CRH’s U.S. focused construction...

If you are wondering whether Sun Communities is reasonably priced at around US$124 per share, you are not alone, as the stock often raises questions about what you are really paying for. Over the last year the share price return is 8.3%, with shorter term moves of 2.4% over 7 days and 1.5% over 30 days. These moves may signal that the market is reassessing either its growth potential or its risks. Recent attention around Sun Communities has focused on its position in the real estate sector...

Zeta Global Holdings announced a collaboration with OpenAI to enhance its Athena AI marketing platform, accelerated the Athena Suite rollout to late first quarter 2026, and recently closed its acquisition of Marigold, while also preparing for a fireside chat at the Needham Growth Conference held on 13 January 2026 in New York. This combination of an OpenAI-powered product roadmap, an expanded marketing software portfolio via Marigold, and near-term investor outreach has sharpened attention...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...